Cyanidin-3-O-β-D-glucopyranoside concentrated materials from mulberry fruit have a potency to protect erectile function by minimizing oxidative stress in a rat model of diabetic erectile dysfunction

Urol Int. 2012;88(4):470-6. doi: 10.1159/000336136. Epub 2012 Mar 14.

Abstract

Objective: The aim of this study was to evaluate the effect of cyanidin-3-O-β-D-glucopyranoside (C3G) concentrated materials from mulberry fruit on improvement and protection of erectile function.

Materials and methods: Sprague-Dawley rats (12 weeks old) were divided into three groups (n = 12 in each): normal control, diabetes mellitus (DM), and DM with C3G concentrated material treatment (DM + C3G). DM and DM + C3G group rats received a single injection of streptozotocin (50 mg/kg), and 4 weeks after induction of diabetes, the DM + C3G group rats were treated with daily concentrated material treatment (10 mg/kg) dissolved in water for 8 weeks. After 12 weeks of streptozotocin injections, the rats in each group underwent intracavernosal pressure measurement and then the corporal tissues were sampled.

Results: The DM group rats showed markedly lower erectile parameters than those in the control group, whereas rats in the DM + C3G group showed improved erectile function by minimizing corporal apoptosis and increasing the expression of endothelial nitric oxide synthase (NOS) and neuronal NOS protein. A significant increase in 8-hydroxy-2-deoxyguanosine (8-OHdG) was shown in the DM group compared with the normal group. However, in the DM + C3G group, 8-OHdG was statistically significantly reduced compared with the DM group.

Conclusions: The current study is the first to suggest that C3G concentrated materials may have a potency to improve and protect erectile function under conditions of diabetes-induced oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Animals
  • Anthocyanins / isolation & purification
  • Anthocyanins / pharmacology*
  • Antioxidants / isolation & purification
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects
  • Deoxyguanosine / analogs & derivatives
  • Deoxyguanosine / metabolism
  • Diabetes Complications / etiology
  • Diabetes Complications / metabolism
  • Diabetes Complications / pathology
  • Diabetes Complications / physiopathology
  • Diabetes Complications / prevention & control*
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / physiopathology
  • Erectile Dysfunction / etiology
  • Erectile Dysfunction / metabolism
  • Erectile Dysfunction / pathology
  • Erectile Dysfunction / physiopathology
  • Erectile Dysfunction / prevention & control*
  • Fruit
  • In Situ Nick-End Labeling
  • Male
  • Morus* / chemistry
  • Nitric Oxide Synthase Type I / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Oxidative Stress / drug effects*
  • Penile Erection / drug effects*
  • Penis / drug effects*
  • Penis / metabolism
  • Penis / pathology
  • Penis / physiopathology
  • Rats
  • Rats, Sprague-Dawley
  • Superoxide Dismutase / metabolism

Substances

  • Anthocyanins
  • Antioxidants
  • cyanidin-3-O-beta-glucopyranoside
  • 8-Hydroxy-2'-Deoxyguanosine
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type III
  • Nos1 protein, rat
  • Nos3 protein, rat
  • Superoxide Dismutase
  • Deoxyguanosine